Consistent and Widespread Degeneration of the Cerebellum in Huntington's Disease (HD)

被引：2
|
作者：
Rueb, Udo [1 ]
Vonsattel, Jean Paul G. [2 ]
Heinsen, Helmut [3 ,4 ]
Korf, Horst-Werner [5 ]
机构：
[1] Goethe Univ Frankfurt, Dr Senckenberg Chronomed Inst, D-60054 Frankfurt, Germany
[2] Columbia Univ, Med Ctr, Neurol Inst, New York, NY USA
[3] Univ Wurzburg, Brain Res Unit, Div Psychiat Clin Morphol, D-97070 Wurzburg, Germany
[4] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil
[5] Goethe Univ Frankfurt, Dr Senckenberg Chronomed Inst, Hessen, Germany
来源：
NEUROPATHOLOGY OF HUNTINGTON'S DISEASE: CLASSICAL FINDINGS, RECENT DEVELOPMENTS AND CORRELATION TO FUNCTIONAL NEUROANATOMY | 2015年 / 217卷
关键词：
D O I：
10.1007/978-3-319-19285-7_5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：54 / 65
页数：12
相关论文
共 50 条
  • [41] Characterizing US Healthcare Delivery in Huntington's Disease (HD)
    Seeberger, L.
    Corey-Bloom, J.
    O'Brien, M.
    Chen, P.
    Griffin, B.
    Schlang, D.
    Slowiejko, D.
    MOVEMENT DISORDERS, 2021, 36 : S109 - S109
  • [42] Impact of caffeine intake on Huntington's disease (HD) course
    Duru, C.
    Simonin, C.
    Richard, F.
    Hincker, P.
    Salleron, J.
    Charles, P.
    Youssov, K.
    Burnouf, S.
    Azulay, J. -P.
    Verny, C.
    Tranchant, C.
    Goizet, C.
    Defebvre, L.
    Sablonniere, B.
    Romon, M.
    Buee, L.
    Amouyel, P.
    Godefroy, O.
    Duerr, A.
    Bachoud-Levi, A. -C.
    Blum, D.
    Krystkowiak, P.
    MOVEMENT DISORDERS, 2010, 25 (07) : S271 - S271
  • [43] Cognitive profiling in a cohort of Huntington's disease (HD) patients
    Garon, M.
    Pistonesi, F.
    Weis, L.
    Cianci, V.
    Gandolfi, T.
    Fiorenzato, E.
    Tedesco, C.
    Campagnolo, M.
    Carecchio, M.
    Antonini, A.
    Biundo, R.
    MOVEMENT DISORDERS, 2022, 37 : S298 - S298
  • [44] An interdisciplinary model of care for Huntington's disease (HD) families
    Rao, A. K.
    Moskowitz, C. B.
    Wasserman, P. L.
    Marder, K. S.
    MOVEMENT DISORDERS, 2012, 27 : S59 - S59
  • [45] DISRUPTION OF MELATONIN CIRCADIAN RHYTHMICITY IN HUNTINGTON'S DISEASE (HD)
    Kalliolia, E.
    Kalliolia, R.
    Silajdzic, E.
    Nambron, R.
    Hill, N.
    Hindmarsh, P.
    Bjorkqvist, M.
    Warner, T.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 : A13 - A14
  • [46] Epidemiology of Huntington's Disease (HD) in the US Medicaid Population
    Exuzides, A.
    Reddy, S.
    Chang, E.
    Paydar, C.
    Yohrling, G.
    MOVEMENT DISORDERS, 2020, 35 : S97 - S97
  • [47] Examining cognitive processing speed in Huntington's disease (HD)
    Herndon, A.
    Nathan, A. S.
    Corey-Bloom, J.
    MOVEMENT DISORDERS, 2015, 30 : S533 - S534
  • [48] Tetrabenazine Use in Patients With Huntington's Disease (HD) Chorea
    Sung, Victor W.
    Iyer, Ravi
    Schilling, Traci
    Buzinec, Paul N.
    NEUROLOGY, 2017, 88
  • [49] Epidemiology of Huntington's Disease (HD) in the US Medicare Population
    Exuzides, Alex
    Crowell, Valerie
    Reddy, Sheila Reiss
    Chang, Eunice
    Yohrling, George
    NEUROLOGY, 2020, 94 (15)
  • [50] Comorbidities in Huntington's disease: An Enroll-HD analysis
    Mills, J.
    Long, J.
    Vaidya, J.
    Sampaio, C.
    Sathe, S.
    MOVEMENT DISORDERS, 2022, 37 : S303 - S304
12345